As a matter of policy, NVS does not disclose sales of individual products that fall below a certain threshold.
(NVS did not disclose 2Q15 Glatopa sales either, but I was able to estimate the number within a small tolerance based on NVS' comments during the 2Q15 CC: #msg-115576637.)
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”